Elevated prostate-specific antigen, abnormal prostate evaluation on digital rectal examination, and transrectal ultrasound and prostate biopsy

Urologic Clinics of North America

Volumn 25, Issue 4, 1998, Pages 581-589

  Partin, A W ^a   Stutzman, R E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER SCREENING; HUMAN; MALE; MEDICAL DECISION MAKING; NEEDLE BIOPSY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0031734515     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70049-5     Document Type: Article

References (68)

1. R.J. Alblin P. Bronson W.A. Soanes Tissue- and species-specific antigens of normal human prostatic tissue J Immunol 104 1970 1329
2. M. Bazinet A.A. Meshref C. Trudel Prospective evaluation of prostate specific antigen density and systematic biopsies for early detection of prostatic carcinoma Urology 43 1994 44
3. M.C. Benson I.S. Whang C.A. Olsson The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen J Urol 147 1992 817
4. M.K. Brawer E.A.G. Aramburu G.L. Chen The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma J Urol 150 1993 369
5. H.B. Carter A.W. Partin Diagnosis and staging of prostate cancer Walsh P.C. Campbell's Urology ed 7 1997 Williams & Wilkins Baltimore 2577 2578
6. H.B. Carter C.H. Morrell J.D. Pearson Estimation of prostatic growth using serial prostate-specific antigen measurement in men with and without prostate disease Cancer Res 52 1992 3323
7. H.B. Carter J.D. Pearson Z. Waclawiw Prostate-specific antigen variability in men without prostate cancer: Effect of sampling interval on prostate-specific antigen velocity Urology 45 1995 591
8. W.S. Catalona D.S. Smith D.K. Ornstein Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination: Enhancement of specificity with free PSA measurements JAMA 277 1997 1452
9. W.J. Catalona D.S. Smith R.L. Wolfert Evaluation of percentage of free serum PSA to improve specificity of prostate cancer screening JAMA 274 1995 1214
10. W.J. Catalona J.P. Richie F.R. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men J Urol 151 1994 1283
11. W.J. Catalona D.S. Smith T.L. Ratliff Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening JAMA 270 1993 948
12. M.E. Chen P. Troncoso D.A. Johnston Optimization of prostate biopsy strategy using computer based analysis J Urol 158 1997 2168
13. C.M. Coley M.J. Barry A.G. Mulley Screening for prostate cancer. American College of Physicians Ann Intern Med 126 1997 480
14. M.S. Cookson M.K. Floyd T.P. Ball The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels J Urol 154 1995 1070
15. W.H. Cooner B.R. Mosley C.L. Rutherford Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer J Urol 139 1988 758
16. F. Daneshgari G.D. Taylor G.J. Miller Computer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsies Urology 45 1995 604
17. W.J. Ellis M.K. Brawer Repeat needle biopsy; Who needs it? J Urol 153 1995 1496
18. J.I. Epstein P.C. Walsh Carmichael M. Brendler C.B. Pathologic and clinical findings to predict tumor extent of non-palpable (stage) T1c prostate cancer JAMA 2718 1994 368 374
19. J.I. Epstein P.C. Walsh H.B. Carter Use of repeat sextant and transition zone biopsies for accessing extent of prostate cancer J Urol 158 1997 1886
20. L.A. Eskew R.L. Bare D.L. McCullough Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate J Urol 157 1997 199
21. N.E. Fleshner M. O'Sullivan W.R. Fair Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate J Urol 158 1997 505
22. P.H. Gann C.H. Hennekens M.J. Stampfer A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer JAMA 273 1995 289
23. R.J. Henderson J.A. Eastham D.J. Culkin Prostate-specific antigen (PSA) and PSA density: Racial differences in men without prostate cancer J Natl Cancer Inst 89 1997 134
24. K.K. Hodge J.E. McNeal T.A. Stamey Ultrasound-guided transrectal core biopsies of the palpably abnormal prostate J Urol 142 1989 66
25. K.K. Hodge J.E. McNeal T.A. Stamey Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate J Urol 142 1989 71
26. D. Kadmon A.D. Weinberg R.H. Williams Pitfalls in interpreting prostate specific antigen velocity J Urol 155 1996 1655
27. D.W. Ketch W.J. Catalona Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values J Urol 154 1995 1795
28. M. Kuriyama M.C. Wang L.D. Papsidero Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay Cancer Res 40 1980 4658
29. H. Lilja A. Christensson U. Dahlen Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin Clin Chem 37 1991 1618
30. P.J. Littrip R.A. Kane C.J. Mettlin Cost-effective prostate cancer detection Cancer 74 1994 3146
31. P.D. Liu M.K. Terris J.E. McNeal Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer J Urol 153 1995 1000
32. A.A. Luderer Y.T. Chen T.F. Soriano Measurement of the proportion of free to total prostate specific antigen improves diagnostic performance of prostate specific antigen in the diagnostic gray zone of total prostate-specific antigen Urology 46 1995 187
33. C. Mettlin F. Lee J. Drago The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men Cancer 67 1991 2949
34. T.O. Morgan S.J. Jacobsen W.F. McCarthy Age-specific reference ranges for serum prostate-specific antigen in black men N Engl J Med 335 1996 304
35. J.W. Moul I.A. Sesterhenn R.R. Connelly Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men JAMA 274 1995 1277
36. G.P. Murphy R.J. Barren S.J. Erickson Evaluation and comparison of two new prostate carcinoma markers Cancer 78 1996 809
37. J.F. Myrtle P.G. Klimley L.P. Ivor Clinical utility of prostate specific antigen (PSA) in the management of prostate cancer Advances in cancer diagnostics 1987 Hybritech Inc. San Diego, CA
38. M. Nishiya C.J. Miller D.H. Lookner Prostate specific antigen density in patients with histologically proven prostate carcinoma Cancer 74 1994 3002
39. G.J. O'Dowd R.W. Veltri J.E. Oesterling Update on the appropriate staging evaluation for newly diagnosed prostate cancer J Urol 158 1997 687
40. J.E. Oesterling S.J. Jacobsen C.G. Chute Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges JAMA 270 1993 860
41. Ornstein G.S. Rao D.S. Smith Digital prostate examination, needle biopsy and the effect on free and total prostate specific antigen levels in prostate cancer screening J Urol 157 1997 195
42. J. Pannek A.W. Partin Prostate-specific Antigen: What's new in 1997 Oncology 2 1997 1273
43. A.W. Partin W.J. Catalona P.C. Southwick Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume, and age Urology 48 6A 1996 55
44. A.W. Partin J.E. Oesterling The clinical usefulness of prostate specific antigen: Update 1994 J Urol 152 1994 1358
45. A.W. Partin J.K. Yoo H.B. Carter The use of prostate-specific antigen, clinical stage and Gleason score to predict pathologic stage in men with prostate cancer J Urol 150 1993 110
46. A.W. Partin H.B. Carter D.W. Chan Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia J Urol 143 1990 747
47. P.A. Peller D.C. Young D.P. Marmaduke Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens Cancer 75 1995 530
48. M.W. Plawker J.M. Fleisher E.M. Vapnek Current trends in prostate cancer diagnosis and staging among United States urologist J Urol 158 1977 1853
49. A.F. Prestigiacomo T.A. Stamey Can free and total prostate specific antigen and prostatic volume distinguish between men and negative and positive systematic ultrasound guided prostate biopsies? J Urol 157 1997 189
50. M.I. Resnick J.A. Smith P.T. Scardino Transrectal prostate ultrasonography: Variability of interpretation J Urol 158 1997 856
51. G.C.G. Roehrborn C.J. Girman K.A. Rhodes Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound Urology 49 1997 548
52. F.M. Rommel V.E. Augusta J.A. Breslin The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice J Urol 151 1994 88
53. E. Seaman I.S. Whang C.A. Olsson PSA density (PSAD): Role in patient evaluation and management Urol Clin North Am 20 1993 653
54. K. Shinohara T.M. Wheeler P.T. Scardino The appearance of prostate cancer on transrectal ultrasonography: Correlation of imaging and pathological examinations J Urol 142 1989 76
55. Smith J.A. Jr P.T. Scardino M.I. Resnick Digital rectal examination versus TRUS, prostate cancer staging J Urol 157 1997 902
56. D.S. Smith W.J. Catalona Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection J Urol 152 1994 1163
57. J.P. Sparnak M.I. Resnick Transrectal ultrasonography Urology 23 1984 461
58. T.A. Stamey Making the most out of six systematic sextant biopsies Urology 45 1995 1
59. T.A. Stamey J.N. Kabalin J.E. McNeil Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients J Urol 141 1989 1076
60. U.H. Stenman J. Leinonen H. Alfthan A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer Cancer Res 51 1991 222
61. M.K. Terris T.Q. Pham M.M. Issa Routine transitional zone and seminal vesicle biopsies in all patient undergoing transrectal ultrasound guided prostate biopsies are not indicated J Urol 157 1997 204
62. M.K. Terris D.J. Hanly T.A. Stamey Prediction of prostate cancer volume using prostate specific antigen levels, transrectal ultrasound, and systematic sextant biopsies Urology 45 1995 75
63. M.K. Terris J.E. McNeal T.A. Stamey Detection of clinically significant prostate cancer by transrectal ultrasound-guided systematic biopsies J Urol 148 1992 829
64. A.R. Vashi K.J. Wojno W. Hendricks Determination of the “reflex-range” and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system Urology 49 1997 19
65. S. Vijayakumar T. Karrison R.R. Weichselbaum Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer Cancer Epidemiol Biomarkers Prev 1 1992 541
66. M.C. Wang L.A. Valenzuela G.P. Murphy Purification of a human prostate specific antigen Invest Urol 17 1979 159
67. X. Wang R.E. Brannigan A.W. Rademaker One core positive prostate biopsy is a poor predictor of cancer volume in the radical prostatectomy specimen J Urol 158 1997 1431
68. D. Woodrum C. French L.B. Shamel Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions Urology 48 6A 1996 33